Kumar Dinesh M.

SEC source: 0001104659-26-039688 · tm2611155-2_4seq1.xml · nonDerivative · entry 2

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,655

F2 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock and restricted stock units that vested on April 1, 2026.

F3 · balance_after: Includes 28,378 shares of restricted stock, which will vest on January 23, 2027 (subject to continuous employment with the Issuer). Also includes 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026 (subject to continuous employment with the Issuer).

F4 · balance_after: Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-26-039688 · tm2611155-2_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,635

F1 · shares: Shares delivered to the reporting person pursuant to the vesting of performance-based restricted stock units that vested upon achievement of performance goals for the applicable performance period. The reporting person reported an acquisition of 67,238 performance-based restricted stock units on a Form 4 filed November 12, 2024, which represented the number of shares that would be delivered if target performance was achieved during the performance period. Actual performance exceeded the target performance for the performance period, which resulted in an additional grant of 35,300 shares.

SEC source: 0001104659-26-025234 · tm268271-2_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,335

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026.

F2 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.

F3 · balance_after: Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-26-007035 · tm264256-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,032

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 23, 2026.

F2 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.

F3 · balance_after: Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-26-000806 · tm261927-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,791

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 1, 2026.

F2 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.

F3 · balance_after: Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-25-088645 · tm2525521-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,893

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025.

F2 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 13,464 shares, which will vest on January 1, 2026; and (iii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.

F3 · balance_after: Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-25-065430 · tm2519743-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,811

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F2 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 13,464 shares, which will vest on January 1, 2026; and (iii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025.

F3 · balance_after: Includes 629 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-25-057334 · tm2517312-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,642

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F2 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 26,927 shares, which will vest in two equal semi-annual installments beginning on July 1, 2025; and (iii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025.

F3 · balance_after: Includes 629 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-25-042820 · tm2513707-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,298

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F2 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 23,663 shares, which will vest in two equal semi-annual installments beginning on July 1, 2025; and (iii) grants of 8,158 shares, 6,527 shares, and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025.

F3 · balance_after: Includes 629 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-25-021863 · tm258649-1_4seq1.xml · nonDerivative · entry 2

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,126

F2 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F3 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 22,021 shares, which will vest in two equal semi-annual installments beginning on July 1, 2025; and (iii) grants of 8,158 shares, 6,527 shares, and 6,527 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025.

F4 · balance_after: Includes 629 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-25-021863 · tm258649-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,992

F1 · shares: Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on September 5, 2025.

SEC source: 0001104659-25-006326 · tm253769-5_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,291

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F2 · balance_after: Includes 115,493 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 6,527 shares, which will vest in two equal semi-annual installments beginning on July 1, 2025; and (iii) grants of 16,316, 16,316, 13,053 and 6,527 shares, each of which will vest subject to the achievement of certain performance goals. Also includes 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals.

F3 · balance_after: Includes 629 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC source: 0001104659-25-000798 · tm251879-1_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,872

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F2 · balance_after: Includes 143,869 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025; (ii) 6,527 shares, which will vest in two equal semi-annual installments beginning on July 1, 2025; and (iii) grants of 16,316, 16,316, 13,053 and 6,527 shares, each of which will vest subject to the achievement of certain performance goals. Also includes 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals.

SEC source: 0001104659-24-116865 · tm2428142-2_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,839

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest subject to the achievement of certain performance goals, provided the Reporting Person is still employed with the Issuer on the date of vesting.

F2 · balance_after: Includes 214,370 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025 (ii) 9,790 shares, which will vest in three equal semi-annual installments beginning on January 1, 2025; and (iii) grants of 16,316, 16,316, 13,053, 6,527 and 67,238 shares, each of which will vest subject to the achievement of certain performance goals.

SEC source: 0001104659-24-085988 · tm2420818-2_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,601

F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F2 · balance_after: Includes 147,132 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025; (ii) 16,316 shares, which will vest subject to the achievement of certain pre-established performance goals; (iii) 16,316 shares, which will vest subject to the achievement of certain pre-established performance goals; (iv) 13,053 shares, which will vest subject to the achievement of certain pre-established performance goals; (v) 9,790 shares, which will vest in three equal semi-annual installments beginning on January 1, 2025; and (vi) 6,527 shares, which will vest subject to the achievement of certain pre-established performance goals.

SEC source: 0001104659-24-006279 · tm244010-2_4seq1.xml · nonDerivative · entry 6

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,395

F6 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.

F7 · balance_after: Includes 150,395 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025; (ii) 16,316 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals; (iii) 16,316 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals;

F8 · balance_after: (cont.) (iv) 13,053 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals; (v) 13,053 shares, which will vest in four equal semi-annual installments beginning July 1, 2024, subject to the achievement of certain performance goals; and (vi) 6,527 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals.

SEC source: 0001104659-24-006279 · tm244010-2_4seq1.xml · nonDerivative · entry 5

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,868

F5 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, the shares will vest in four equal semi-annual installments beginning on July 1, 2024.

SEC source: 0001104659-24-006279 · tm244010-2_4seq1.xml · nonDerivative · entry 4

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,815

F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.

SEC source: 0001104659-24-006279 · tm244010-2_4seq1.xml · nonDerivative · entry 3

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,762

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.

SEC source: 0001104659-24-006279 · tm244010-2_4seq1.xml · nonDerivative · entry 2

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,446

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.

SEC source: 0001104659-24-006279 · tm244010-2_4seq1.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,130

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares will vest in three equal annual installments beginning on January 23, 2025, subject to accelerated vesting in certain cases.

SEC source: 0001209191-23-021891 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,088,651

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-018987 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,091,937

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-006991 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,106,101

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.41. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-004325 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,116,101

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-003777 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,117,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.18. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-001934 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,126,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-059510 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,127,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.82 to $13.43. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-055299 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,147,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.09 to $13.82. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-054807 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,177,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.08. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-052900 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,187,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.69 to $12.28. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-049769 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,207,226

F1 · kind: Represents 280,360 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 50% on each of the third and fourth anniversaries of the grant date, subject to the reporting person's continued service to the Company.

SEC source: 0001209191-22-049371 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 926,866

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.00 to $16.2150. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-048487 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 976,866

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.31 to $14.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-047482 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,006,866

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.00 to $16.0550. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-045016 · doc4.xml · nonDerivative · entry 2

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,056,866

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.00 to $19.13.

SEC source: 0001209191-22-045016 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,059,397

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.00 to $18.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4.

SEC source: 0001209191-22-044012 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,100,970

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

SEC source: 0001209191-22-041519 · doc4.xml · nonDerivative · entry 2

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,130,970

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported prices in column 4 are weighted-average prices. Shares sold on July 5, 2022 were sold in multiple transactions at a per share price ranging from $12.00 to $12.88. Shares sold on July 6, 2022 were sold in multiple transactions at a per share price ranging from $13.00 to $13.26. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-041519 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,150,970

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported prices in column 4 are weighted-average prices. Shares sold on July 5, 2022 were sold in multiple transactions at a per share price ranging from $12.00 to $12.88. Shares sold on July 6, 2022 were sold in multiple transactions at a per share price ranging from $13.00 to $13.26. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-040366 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,167,287

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.02 to $11.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-038942 · doc4.xml · nonDerivative · entry 2

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,177,287

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

SEC source: 0001209191-22-038942 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,177,387

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-038053 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,180,970

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-022078 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,190,970

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-018005 · doc4.xml · derivative · entry 2

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,068

Underlying: Common Stock · 152,068 shares

Expires 2032-03-08

F2 · derivative.exercise_date: Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001209191-22-018005 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,194,028

F1 · kind: Represents 206,954 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company.

SEC source: 0000950142-21-003815 · es210205305_4-kumar.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 987,074

F1 · kind: Represents 83,367 shares of Common Stock sold pursuant to a registered offering which closed on November 23, 2021, at a price of $20.1075 (net of underwriting discount).

SEC source: 0001209191-21-062735 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,070,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported price in column 4 is a weighted-average price. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4.

F2 · price: The shares were sold in multiple transactions at prices ranging from $19.37 to $20.13 per share.

SEC source: 0000950142-21-003199 · es210192797_4-kumar.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,080,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4.

F2 · price: The shares were sold in multiple transactions at prices ranging from $18.00 to $18.34 per share.